Novel preadipocyte factor-1-like polypeptides
CA 2511564 A1 · Owner: Applied Research Systems Ars Holding N.V. · Inventors: Mcallister, Gregg; Bienkowska, Jadwiga
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention discloses open reading frames (ORFs) in human genome encoding for novel Preadipocyte factor-1-like polypeptides and reagents , related thereto including variants mutants and fragments of said , polypeptides as well as ligands and antagonists directed against them. The invention provides methods for identifying and making these molecules for , preparing pharmaceutical compositions containing them and for using them in , the diagnosis, prevention and treatment of diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 23, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 23, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 23, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.